BioCardia Enhances Leadership with New Appointment
BioCardia, Inc. [NASDAQ: BCDA], a leading entity in cellular and cell-derived therapeutics aimed at addressing cardiovascular and pulmonary conditions, is excited to announce the addition of Farhan Shahab as the Vice President of Quality.
Farhan Shahab's Impressive Background
With a wealth of over 25 years in the field, Mr. Shahab arrives at BioCardia with significant experience in various executive roles, particularly in the areas of quality and regulatory compliance. His previous position was at Welldoc, a company specializing in digital health solutions for chronic disease management, where he also served as VP of Quality and Regulatory.
Throughout his career, Mr. Shahab has held pivotal roles including Senior Director of Regulatory Affairs and Quality Assurance at Intuity Medical, a prominent player in blood glucose monitoring technologies. He also contributed as Director of Quality Assurance and Regulatory Compliance at Moximed, focusing on orthopedic devices, and has experience as Senior Director of Quality Engineering at AngioScore, known for its catheter products. Mr. Shahab began his career at Medtronic, where he was engaged in the critical integration of quality systems following major acquisitions.
Educational Qualifications and Certifications
Mr. Shahab holds a Bachelor of Science degree in Chemical Engineering from the University of Massachusetts and an MBA from the University of Phoenix. He is recognized as a Regulatory Affairs Certified (RAC) professional and a Certified Auditor through Exemplar Global, showcasing his commitment to excellence in quality systems compliance and regulatory alignment.
Leadership Insights on Mr. Shahab's Appointment
Peter Altman, PhD, the CEO of BioCardia, expressed his enthusiasm for this new appointment, stating, “Farhan’s expertise in product quality management and supporting regulatory submissions across various product categories will be invaluable to our team. We are thrilled to welcome Farhan, whose proven leadership and extensive relevant experience have the potential to accelerate our endeavors in commercializing our investigational products.”
About BioCardia
Headquartered in Sunnyvale, California, BioCardia, Inc. stands at the forefront of innovation in cellular and cell-derived therapeutic methodologies. The company's flagship products include CardiAMP® and CardiALLO™, representing advanced cell therapy platforms currently undergoing clinical trials. BioCardia's development activities are enabled by technologies like the Helix™ biotherapeutic delivery system and Morph® vascular navigation platform.
To explore more about the innovative solutions offered by BioCardia, visit https://www.BioCardia.com.
Frequently Asked Questions
Who is Farhan Shahab?
Farhan Shahab is the newly appointed Vice President of Quality at BioCardia, bringing over 25 years of experience in quality management and regulatory affairs.
What are Mr. Shahab's qualifications?
He holds a BS in Chemical Engineering and an MBA, along with professional certifications in regulatory affairs and auditing.
What is BioCardia known for?
BioCardia is recognized for its advancements in cellular and cell-derived therapies targeting cardiovascular and pulmonary diseases.
What products are in development at BioCardia?
The company is advancing clinical-stage product candidates, including its CardiAMP® and CardiALLO™ biotherapeutics.
How does Mr. Shahab's experience benefit BioCardia?
His extensive background in quality and regulatory compliance will enhance BioCardia’s capabilities in product commercialization and ensure compliance with quality standards.
